{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T09:14:32Z","timestamp":1785402872811,"version":"3.56.0"},"reference-count":42,"publisher":"MDPI AG","issue":"15","license":[{"start":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T00:00:00Z","timestamp":1785369600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Nicolaus Copernicus University"},{"id":[{"id":"https:\/\/ror.org\/0102mm775","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Clin. Med.","JCM"],"abstract":"<jats:p>Background\/Objectives: Heart failure with reduced ejection fraction (HFrEF) involves coexisting inflammatory and hemostatic dysregulation contributing to thromboembolic and bleeding risk. Ten-eleven translocation (TET1-3) proteins regulate immune-cell phenotype, but their relationship to plasma coagulation parameters in HFrEF is poorly defined. We aimed to determine whether TET1-3 protein expression in peripheral blood leukocyte subpopulations is associated with routinely available plasma coagulation parameters in HFrEF, and whether associations differ by direct oral anticoagulant (DOAC) exposure and clinical phase. Methods: In this cross-sectional, observational, two-center study, 107 patients with HFrEF were enrolled (39 receiving a DOAC, non-randomized; 68 not receiving a DOAC, of whom seven received a vitamin K antagonist and 61 received no oral anticoagulant). TET1-3 protein expression was assessed by flow cytometry in T lymphocytes, B lymphocytes, natural killer (NK) cells, monocytes, and granulocytes, expressed as the ratio of test-to-negative-control geometric mean fluorescence intensity. Associations with activated partial thromboplastin time (aPTT) and international normalized ratio (INR) were analyzed using nonparametric tests and Spearman correlations; DOAC samples were drawn at steady-state trough. Results: DOAC-treated patients constituted a distinct clinical subgroup (older, predominantly AF\/AFL) and showed longer aPTT and higher TET expression in selected immune-cell subsets; these between-group differences cannot be attributed to DOAC therapy. Patients with aPTT at or above the median showed higher TET expression in T cells, B cells, NK cells, and selected leukocyte indices, whereas INR-based stratification did not. In continuous analyses, TET indices showed multiple moderate positive Spearman correlations (R = 0.25\u20130.49) with both aPTT and INR\u2014with INR showing the strongest single association\u2014and no associations with composite inflammatory indices (NLR, SII, SIRI); all comparisons were exploratory and uncorrected for multiplicity. Associations appeared stronger in stable than in worsening HFrEF (exploratory). Conclusions: Peripheral leukocyte TET protein expression was associated with plasma coagulation parameters in HFrEF; the aPTT-specific pattern was confined to the categorical (median-split) analysis, whereas continuous analyses showed associations with both aPTT and INR. Because of the cross-sectional design, moderate sample size, and potential confounding by indication, these findings should be considered hypothesis-generating. TET-related immune-cell phenotyping may capture a non-redundant immune\u2013coagulation signal in HFrEF and warrants prospective validation.<\/jats:p>","DOI":"10.3390\/jcm15155942","type":"journal-article","created":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T08:09:42Z","timestamp":1785398982000},"page":"5942","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Peripheral Leukocyte TET Protein Expression Is Associated with Plasma Coagulation Parameters in Patients with Heart Failure with Reduced Ejection Fraction: A Two-Center Cross-Sectional Study"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7536-7809","authenticated-orcid":false,"given":"Anna","family":"Wo\u0142owiec","sequence":"first","affiliation":[{"name":"Department of Geriatrics, Faculty of Health Sciences, Ludwik Rydygier Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toru\u0144, 85-094 Bydgoszcz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7731-6367","authenticated-orcid":false,"given":"\u0141ukasz","family":"Wo\u0142owiec","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Clinical Pharmacology, Faculty of Health Sciences, Ludwik Rydygier Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toru\u0144, 85-168 Bydgoszcz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6669-5931","authenticated-orcid":false,"given":"Grzegorz","family":"Grze\u015bk","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Clinical Pharmacology, Faculty of Health Sciences, Ludwik Rydygier Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toru\u0144, 85-168 Bydgoszcz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3556-5821","authenticated-orcid":false,"given":"Jacek","family":"Budzy\u0144ski","sequence":"additional","affiliation":[{"name":"Department of Vascular and Internal Diseases, Faculty of Health Sciences, Ludwik Rydygier Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toru\u0144, 85-094 Bydgoszcz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Banach","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Clinical Pharmacology, Faculty of Health Sciences, Ludwik Rydygier Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toru\u0144, 85-168 Bydgoszcz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Osiak-Gwiazdowska","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Clinical Pharmacology, Faculty of Health Sciences, Ludwik Rydygier Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toru\u0144, 85-168 Bydgoszcz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Ja\u015bniak","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Clinical Pharmacology, Faculty of Health Sciences, Ludwik Rydygier Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toru\u0144, 85-168 Bydgoszcz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulina","family":"Jakubowska","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Cardiac Surgery, 10th Military Clinical Hospital, 85-681 Bydgoszcz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6988-3038","authenticated-orcid":false,"given":"Mariusz","family":"Kozakiewicz","sequence":"additional","affiliation":[{"name":"Department of Geriatrics, Faculty of Health Sciences, Ludwik Rydygier Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toru\u0144, 85-094 Bydgoszcz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,7,30]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.cardfail.2024.07.001","article-title":"Heart Failure Epidemiology and Outcomes Statistics: A Report of the Heart Failure Society of America","volume":"31","author":"Bozkurt","year":"2025","journal-title":"J. Card. Fail."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/ejhf.2742","article-title":"Inflammation across the Universal Definition of Heart Failure Stages: The CASABLANCA Study","volume":"25","author":"Mohebi","year":"2023","journal-title":"Eur. J. Heart Fail."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s10741-020-09994-0","article-title":"Direct Oral Anticoagulants across the Heart Failure Spectrum: The Precision Medicine Era","volume":"27","author":"Paolillo","year":"2022","journal-title":"Heart Fail. Rev."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Marcos-Jubilar, M., Lecumberri, R., and P\u00e1ramo, J.A. (2023). Immunothrombosis: Molecular Aspects and New Therapeutic Perspectives. J. Clin. Med., 12.","DOI":"10.3390\/jcm12041399"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/nri3345","article-title":"Thrombosis as an Intravascular Effector of Innate Immunity","volume":"13","author":"Engelmann","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"3324","DOI":"10.7150\/ijbs.109917","article-title":"Heart Failure, Inflammation and Exercise","volume":"21","author":"Luo","year":"2025","journal-title":"Int. J. Biol. Sci."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1002\/ehf2.15090","article-title":"Commonalities of Platelet Dysfunction in HFpEF and Underlying Comorbidities","volume":"12","author":"Schroen","year":"2025","journal-title":"ESC Heart Fail."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Vilella-Figuerola, A., Padr\u00f3, T., Roig, E., Mirabet, S., and Badimon, L. (2022). New Factors in Heart Failure Pathophysiology: Immunity Cells Release of Extracellular Vesicles. Front. Cardiovasc. Med., 9.","DOI":"10.3389\/fcvm.2022.939625"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Atzemian, N., Kareli, D., Ragia, G., and Manolopoulos, V.G. (2023). Distinct Pleiotropic Effects of Direct Oral Anticoagulants on Cultured Endothelial Cells: A Comprehensive Review. Front. Pharmacol., 14.","DOI":"10.3389\/fphar.2023.1244098"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1956284","DOI":"10.1080\/21688370.2021.1956284","article-title":"Rivaroxaban Protects from Oxysterol-Induced Damage and Inflammatory Activation of the Vascular Endothelium","volume":"9","author":"Broncel","year":"2021","journal-title":"Tissue Barriers"},{"key":"ref_11","first-page":"22","article-title":"Rivaroxaban as a Protector of Oxidative Stress-Induced Vascular Endothelial Glycocalyx Damage via the IQGAP1\/PAR1-2\/PI3K\/Akt Pathway","volume":"62","author":"Kitasato","year":"2025","journal-title":"J. Vasc. Res."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.thromres.2019.10.007","article-title":"Effect of Rivaroxaban and Dabigatran on Platelet Functions: In Vitro Study","volume":"183","author":"Jourdi","year":"2019","journal-title":"Thromb. Res."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.jphs.2018.07.002","article-title":"Factor Xa Inhibition by Rivaroxaban Attenuates Cardiac Remodeling Due to Intermittent Hypoxia","volume":"137","author":"Imano","year":"2018","journal-title":"J. Pharmacol. Sci."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.ijcard.2016.06.212","article-title":"Rivaroxaban, a Factor Xa Inhibitor, Induces the Secondary Prevention of Cardiovascular Events after Myocardial Ischemia\u2013Reperfusion Injury in Mice","volume":"220","author":"Goto","year":"2016","journal-title":"Int. J. Cardiol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.jacbts.2021.09.010","article-title":"Rivaroxaban, a Direct Oral Factor Xa Inhibitor, Attenuates Atherosclerosis by Alleviating Factor Xa\u2013PAR2-Mediated Autophagy Suppression","volume":"6","author":"Ito","year":"2021","journal-title":"JACC Basic Transl. Sci."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.jacbts.2021.10.015","article-title":"Pleiotropic, Cellular Effects of Rivaroxaban on Autophagy Explain Atheroprotective Effects","volume":"6","author":"Posma","year":"2021","journal-title":"JACC Basic Transl. Sci."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1161\/CIRCRESAHA.120.317219","article-title":"Different DOACs Control Inflammation in Cardiac Ischemia\u2013Reperfusion Differently","volume":"128","author":"Gadi","year":"2021","journal-title":"Circ. Res."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"e202300014","DOI":"10.1002\/prca.202300014","article-title":"Proteomic Analysis of Extracellular Vesicle Cargoes Mirror the Cardioprotective Effects of Rivaroxaban in Patients with Venous Thromboembolism","volume":"18","author":"Weiss","year":"2024","journal-title":"Proteom. Clin. Appl."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Mele, M., Mele, A., Imbrici, P., Samarelli, F., Purgatorio, R., Dinoi, G., Correale, M., Nicolotti, O., De Luca, A., and Brunetti, N.D. (2024). Pleiotropic Effects of Direct Oral Anticoagulants in Chronic Heart Failure and Atrial Fibrillation: Machine Learning Analysis. Molecules, 29.","DOI":"10.3390\/molecules29112651"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1093\/cvr\/cvaa263","article-title":"Pleiotropic Actions of Factor Xa Inhibition in Cardiovascular Prevention: Mechanistic Insights and Implications for Anti-Thrombotic Treatment","volume":"117","author":"Guzik","year":"2021","journal-title":"Cardiovasc. Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1146\/annurev-immunol-080223-044610","article-title":"TET Enzymes in the Immune System: From DNA Demethylation to Immunotherapy, Inflammation, and Cancer","volume":"42","author":"Ko","year":"2024","journal-title":"Annu. Rev. Immunol."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Tsiouplis, N.J., Bailey, D.W., Chiou, L.F., Wissink, F.J., and Tsagaratou, A. (2021). TET-Mediated Epigenetic Regulation in Immune Cell Development and Disease. Front. Cell Dev. Biol., 8.","DOI":"10.3389\/fcell.2020.623948"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2494","DOI":"10.1038\/s44319-025-00439-z","article-title":"Developmental Epigenetic Programming by Tet1\/3 Determines Peripheral CD8 T Cell Fate","volume":"26","author":"Thurman","year":"2025","journal-title":"EMBO Rep."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"111267","DOI":"10.1016\/j.jbc.2026.111267","article-title":"TET2 in Epigenetic Control of Immune Cells: Implications for Inflammatory Responses and Age-Related Pathologies","volume":"302","author":"Obrebski","year":"2026","journal-title":"J. Biol. Chem."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"106","DOI":"10.4049\/immunohorizons.2200067","article-title":"TET Proteins in the Spotlight: Emerging Concepts of Epigenetic Regulation in T Cell Biology","volume":"7","author":"Tsagaratou","year":"2023","journal-title":"Immunohorizons"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.jacc.2017.12.037","article-title":"Tet2-Mediated Clonal Hematopoiesis Accelerates Heart Failure Through a Mechanism Involving the IL-1\u03b2\/NLRP3 Inflammasome","volume":"71","author":"Sano","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"e135204","DOI":"10.1172\/jci.insight.135204","article-title":"Tet2-Mediated Clonal Hematopoiesis in Nonconditioned Mice Accelerates Age-Associated Cardiac Dysfunction","volume":"5","author":"Wang","year":"2020","journal-title":"JCI Insight"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"e2353244","DOI":"10.1001\/jamanetworkopen.2023.53244","article-title":"Clonal Hematopoiesis and Incident Heart Failure with Preserved Ejection Fraction","volume":"7","author":"Schuermans","year":"2024","journal-title":"JAMA Netw. Open"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1161\/CIRCULATIONAHA.123.065597","article-title":"Clonal Hematopoiesis of Indeterminate Potential with Loss of Tet2 Enhances Risk for Atrial Fibrillation through NLRP3 Inflammasome Activation","volume":"149","author":"Lin","year":"2024","journal-title":"Circulation"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Bai, Y., Wang, X., Lin, N., Li, R., Hu, W., Wang, J., Chen, C., Liu, J., Feng, J., and Li, F. (2025). Unravelling the Role of TET2 in Venous Thromboembolism: Insights into Mechanisms and Therapeutic Implications. Front. Cardiovasc. Med., 12.","DOI":"10.3389\/fcvm.2025.1577303"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/j.jacc.2024.11.052","article-title":"Biomarker-Based Model for Prediction of Ischemic Stroke in Patients with Atrial Fibrillation","volume":"85","author":"Wallentin","year":"2025","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"7042","DOI":"10.1038\/s41467-025-62218-7","article-title":"Biomarker Panels for Improved Risk Prediction and Enhanced Biological Insights in Patients with Atrial Fibrillation","volume":"16","author":"Meyre","year":"2025","journal-title":"Nat. Commun."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur. Heart J."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/jth.13912","article-title":"Laboratory Testing in Patients Treated with Direct Oral Anticoagulants: A Practical Guide for Clinicians","volume":"16","author":"Douxfils","year":"2018","journal-title":"J. Thromb. Haemost."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.chest.2016.08.1462","article-title":"Laboratory Assessment of the Anticoagulant Activity of Direct Oral Anticoagulants: A Systematic Review","volume":"151","author":"Samuelson","year":"2017","journal-title":"Chest"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Wo\u0142owiec, A., Wo\u0142owiec, \u0141., Ja\u015bniak, A., Grz\u0119sk, G., Budzy\u0144ski, J., Osiak-Gwiazdowska, J., Jakubowska, P., Gordon, P., and Kozakiewicz, M. (2026). Differential TET1\/2\/3 Protein Expression in Circulating Leukocytes of Statin-Treated Patients with HFrEF. Curr. Issues Mol. Biol., 48.","DOI":"10.3390\/cimb48050467"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1038\/nbt1210-1248","article-title":"Towards a Knowledge-Based Human Protein Atlas","volume":"28","author":"Uhlen","year":"2010","journal-title":"Nat. Biotechnol."},{"key":"ref_38","first-page":"5.1.1","article-title":"Collection, Storage, and Preparation of Human Blood Cells","volume":"73","author":"Dagur","year":"2015","journal-title":"Curr. Protoc. Cytom."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"21345","DOI":"10.1038\/s41598-021-00880-9","article-title":"The Urinary Excretion of Epigenetically Modified DNA as a Marker of Pediatric ALL Status and Chemotherapy Response","volume":"11","author":"Gackowski","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/jth.13194","article-title":"The Contact Activation and Kallikrein\/Kinin Systems: Pathophysiologic and Physiologic Activities","volume":"14","author":"Schmaier","year":"2016","journal-title":"J. Thromb. Haemost."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/cei.13011","article-title":"Complement and Contact System Activation in Acute Congestive Heart Failure Patients","volume":"190","author":"Suffritti","year":"2017","journal-title":"Clin. Exp. Immunol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"42532","DOI":"10.1038\/srep42532","article-title":"The Alternative Complement Pathway Is Dysregulated in Patients with Chronic Heart Failure","volume":"7","author":"Shahini","year":"2017","journal-title":"Sci. Rep."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/15\/5942\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T08:39:52Z","timestamp":1785400792000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/15\/5942"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,30]]},"references-count":42,"journal-issue":{"issue":"15","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["jcm15155942"],"URL":"https:\/\/doi.org\/10.3390\/jcm15155942","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,30]]}}}